Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1978-04-07
1980-03-04
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
260112B, 2602393R, 424 12, 424 8, 23230B, G01N 3316, A61K 4300, A61K 3900, G21H 502
Patent
active
041917383
ABSTRACT:
Highly specific antibodies to N-desmethyldiazepam are obtained by using as an immunogen 4'-hydrazinocarbonylmethoxy-N-desmethyldiazepam coupled to an immunogenic carrier material such as bovine serum albumin. These antibodies can be employed in immunoassays for N-desmethyldiazepam which is a major metabolite of three important psychoactive drugs diazepam, chlordiazepoxide and clorazepate.
REFERENCES:
patent: 3966764 (1976-06-01), Goldstein et al.
patent: 4058511 (1977-11-01), Singh
Callwood James H.
Gould George M.
Hoffmann-La Roche Inc.
Nucker Christine M.
Padgett Benjamin R.
LandOfFree
Immunoassay for N-desmethyldiazepam does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunoassay for N-desmethyldiazepam, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoassay for N-desmethyldiazepam will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2039926